Clicky

Fortress Biotech, Inc.(FBIO) News

Date Title
May 15 Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 15 AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates
May 15 Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 14 Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation
May 13 Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 13 Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 10 Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
May 7 Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
May 2 Mustang Bio Announces Closing of $4 Million Public Offering
May 1 Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
Apr 30 Mustang Bio Announces Pricing of $4 Million Public Offering
Apr 29 Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Apr 25 Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
Apr 24 Avenue Therapeutics Announces Reverse Stock Split
Mar 28 Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Mar 28 Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
Mar 25 Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
Mar 22 Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Mar 21 Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Mar 18 Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights